5 research outputs found
Comparison of Once‐Daily versus Twice‐Daily Combination Antiretroviral Therapy in Treatment‐Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48‐Week Randomized Controlled Trial
Dosing frequency is an important determinant of regimen effectiveness
Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095
Recommended from our members